Natalizumab and Central Nervous System Lymphoma: No Clear Association

被引：17
作者：
Bozic, Carmen [1 ]
LaGuette, Julia [1 ]
Panzara, Michael A. [1 ]
Sandrock, Alfred W. [1 ]
机构：
[1] Biogen Idec Inc, Cambridge, MA USA
来源：
ANNALS OF NEUROLOGY | 2009年 / 66卷 / 03期
关键词：
RELAPSING MULTIPLE-SCLEROSIS;
D O I：
10.1002/ana.21835
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：261 / 262
页数：2
相关论文
共 12 条
  • [1] Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
    Balcer, L. J.
    Galetta, S. L.
    Calabresi, P. A.
    Confavreux, C.
    Giovannoni, G.
    Havrdova, E.
    Hutchinson, M.
    Kappos, L.
    Lublin, F. D.
    Miller, D. H.
    O'Connor, P. W.
    Phillips, J. T.
    Polman, C. H.
    Radue, E.-W.
    Rudick, R. A.
    Stuart, W. H.
    Wajgt, A.
    Weinstock-Guttman, B.
    Wynn, D. R.
    Lynn, F.
    Panzara, M. A.
    [J]. NEUROLOGY, 2007, 68 (16) : 1299 - 1304
  • [2] DETECTION OF EBER-1 RNA IN PRIMARY BRAIN LYMPHOMAS IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS
    BASHIR, R
    MCMANUS, B
    CUNNINGHAM, C
    WEISENBURGER, D
    HOCHBERG, F
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1994, 20 (01) : 47 - 53
  • [3] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA IMITATES MULTIPLE-SCLEROSIS
    DEANGELIS, LM
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1990, 9 (02) : 177 - 181
  • [4] Harris NL., 2001, PATHOLOGY GENETICS, P264
  • [5] Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
    Havrdova, Eva
    Galetta, Steven
    Hutchinson, Michael
    Stefoski, Dusan
    Bates, David
    Polman, Chris H.
    O'Connor, Paul W.
    Giovannoni, Gavin
    Phillips, J. Theodore
    Lublin, Fred D.
    Pace, Amy
    Kim, Richard
    Hyde, Robert
    [J]. LANCET NEUROLOGY, 2009, 8 (03) : 254 - 260
  • [6] Primary CNS lymphoma
    Hochberg, Fred H.
    Baehring, Joachim M.
    Hochberg, Ephraim P.
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (01): : 24 - 35
  • [7] Epstein Barr Virus-Associated Primary CNS Lymphomas in Elderly Patients on Immunosuppressive Medications
    Kleinschmidt-DeMasters, B. K.
    Damek, Denise M.
    Lillehei, Kevin O.
    Dogan, Ahmed
    Giannini, Caterina
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (11) : 1103 - 1111
  • [8] The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma - A surveillance, epidemiology, and end results analysis
    Olson, JE
    Janney, CA
    Rao, RD
    Cerhan, JR
    Kurtin, PJ
    Schiff, D
    Kaplan, RS
    O'Neill, BP
    [J]. CANCER, 2002, 95 (07) : 1504 - 1510
  • [9] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    Polman, CH
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Toal, M
    Lynn, F
    Panzara, MA
    Sandrock, AW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) : 899 - 910
  • [10] Epstein-Barr virus-associated lymphoproliferative disorders
    Rezk, Sherif A.
    Weiss, Lawrence M.
    [J]. HUMAN PATHOLOGY, 2007, 38 (09) : 1293 - 1304
12